Results 51 to 60 of about 845,747 (311)
Modulation of CD4 by suramin [PDF]
SUMMARYSuramin is a polysulphonated compound which can selectively bind to, and inhibit the activity of, a wide range of growth factors. There has been renewed interest recently in suramin as an anti-cancer agent and therefore we have studied its effects on lymphocyte subset populations and recombinant human IL-2 (rhIL-2) activation on lymphocytes in ...
P D, Allen +4 more
openaire +2 more sources
CD4-WTLAT traffics from the cell surface to the lysosome in activated cells.
A. JCam2.5 cells stably expressing CD4-WTLAT or CD4-2KRLAT were treated with 1mg/ml Leupeptin for 4 hrs. Cells were then labeled with anti-CD4 (clone OKT4) at 4°C, dropped onto stimulatory coverslips at 37°C and fixed after 30 minutes.
Katherine M. McIntire (8478726) +6 more
core +1 more source
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy. [PDF]
Epstein-Barr virus (EBV) is associated with a number of human malignancies. EBV-positive post-transplant lymphoproliferative disease in solid organ and hematopoietic stem cell transplant recipients has been successfully treated by the adoptive transfer ...
Burdach, S. +38 more
core +1 more source
The Protective Role of L-carnitine on Immune Function in Mice Infected with E. coli [PDF]
This study aimed to examine the immunological, molecular, and histopathological changes induced by L-carnitine supplementation in BALB/c mice infected with Escherichia coli.
Taghreed Humadai +2 more
doaj +1 more source
Plasma membranes contain dynamic nanoscale domains that organize lipids and receptors. Because viruses operate at similar scales, this architecture shapes early infection steps, including attachment, receptor engagement, and entry. Using influenza A virus and HIV‐1 as examples, we highlight how receptor nanoclusters, multivalent glycan interactions ...
Jan Schlegel, Christian Sieben
wiley +1 more source
Objective/Background: Chronic lymphocytic leukemia is one of the commonest leukemias affecting adults. CD39 inhibits T-cell and Natural killer (NK) cell responses by hydrolyzing adenosine triphosphate and adenosine diphosphate, suppressing the immune ...
Eman Mosaad Zaki +5 more
doaj +1 more source
Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1 [PDF]
CD4 is the primary receptor for human immunodeficiency virus (HIV). The binding site for the surface glycoprotein of HIV type 1 (HIV-1), gp120, has been mapped to the C'-C" region of domain 1 of CD4. Previously, we have shown that a mutant of rat CD4, in
Puklavec, M. +7 more
core
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
Bioinformatically analyzed relationships between specific human genes associated with HIV attachment
Introduction. Assessing interaction between the human immunodeficiency virus (HIV) and human factors is crucial for understanding the disease pathogenesis. HIV triggers an immune response that involves numerous cellular and molecular processes related to
Vladimir S. Davydenko +5 more
doaj +1 more source
OX40 (CD134) is a co-stimulatory molecule mostly expressed on activated T lymphocytes. Previous reports have shown that OX40 can be an immuno-oncology target and a clinical biomarker for cancers of various organs.
Hiroshi Yokouchi +23 more
doaj +1 more source

